Breaking News Instant updates and real-time market news.

EVBG

Everbridge

$42.28

0.34 (0.81%)

, CSOD

Cornerstone OnDemand

$46.94

-0.28 (-0.59%)

04:55
05/16/18
05/16
04:55
05/16/18
04:55

Needham to hold a conference

2018 Emerging Technology Conference will be held in New York on May 15-16.

EVBG

Everbridge

$42.28

0.34 (0.81%)

CSOD

Cornerstone OnDemand

$46.94

-0.28 (-0.59%)

CVON

ConvergeOne

$9.15

0.24 (2.69%)

UPLD

Upland Software

$31.20

-0.24 (-0.76%)

SFLY

Shutterfly

$92.41

0.08 (0.09%)

EFII

Electronics for Imaging

$33.25

0.1 (0.30%)

ENVA

Enova International

$34.05

1.525 (4.69%)

CMPR

Cimpress

$138.22

0.05 (0.04%)

AMBR

Amber Road

$9.35

-0.06 (-0.64%)

RUBI

Rubicon Project

$2.15

0.03 (1.42%)

VDSI

Ticker changed to OSPN

$20.80

0.45 (2.21%)

JCOM

j2 Global

$85.59

0.23 (0.27%)

  • 16

    May

  • 16

    May

  • 17

    May

  • 21

    May

  • 29

    May

  • 30

    May

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 06

    Jun

  • 12

    Jun

EVBG Everbridge
$42.28

0.34 (0.81%)

05/08/18
FBCO
05/08/18
NO CHANGE
Target $46
FBCO
Outperform
Everbridge price target raised to $46 from $38 at Credit Suisse
Credit Suisse analyst Michael Nemeroff raised his price target for Everbridge to $46 from $38 as large, multi-product deals drive "strong" Q1 results. The analyst reiterates an Outperform rating on the shares.
05/08/18
NEED
05/08/18
NO CHANGE
Target $46
NEED
Buy
Everbridge price target raised to $46 from $40 at Needham
Needham analyst Scott Berg raised his price target on Everbridge to $46 after its "very good" Q1 earnings and FY18 outlook. The analyst also notes "impressive" metrics for the quarter, with a "nearly four-fold increase in six figure contracts sold". Berg keeps his Buy rating on Everbridge with a positive view of the company's discussion of "shifting corporate sales to a more vertically focused effort", which he says can shorten sales cycles and drive higher FY19 bookings.
05/08/18
KEYB
05/08/18
NO CHANGE
Target $45
KEYB
Overweight
Everbridge price target raised to $45 from $39 at KeyBanc
KeyBanc analyst Brent Bracelin raised his price target for Everbridge to $45 from $39 after the company delivered a "strong" quarter. The analyst reiterates an Overweight rating on the shares.
05/08/18
ADAM
05/08/18
NO CHANGE
Target $46
ADAM
Buy
Everbridge remains a favorite small-cap stock, says Canaccord
Canaccord analyst Richard Davis noted Everbridge continued to execute well during the recent quarter with all of the revenue growth in the quarter coming from organic sources. He also notes the quiet but important addition of new features, geographies, and customer types. Davis reiterated his Buy rating and raised his price target to $46 from $40 on Everbridge shares.
CSOD Cornerstone OnDemand
$46.94

-0.28 (-0.59%)

05/09/18
JMPS
05/09/18
NO CHANGE
Target $60
JMPS
Outperform
Cornerstone OnDemand price target increased to $60 from $48 at JMP Securities
JMP Securities analyst Patrick Walravens increased his price target to $60 from $48 on Cornerstone OnDemand after the company reported Q1 results he called "strong," stating that he believes the company has executed effectively over the past six months while concurrently undergoing a "private equity-style transformation" to become leaner and more efficient. Walravens keeps an Outperform rating on Cornerstone OnDemand shares.
05/09/18
MUFG
05/09/18
NO CHANGE
Target $45
MUFG
Neutral
Cornerstone OnDemand price target raised to $45 from $41 at MUFG
MUFG analyst Stephen Bersey raised his price target for Cornerstone OnDemand to $45 saying the company had a "solid" Q1 as its five-point strategic plan "began to bear fruit." The analyst, however, thinks Cornerstone is in the early stages of improving its operating fundamentals. He cautions against extrapolating the initial pace of improvements through the entire transition and reiterates a Neutral rating on the shares.
03/19/18
JMPS
03/19/18
NO CHANGE
Target $48
JMPS
Outperform
Any weakness in Cornerstone OnDemand a buying opportunity, says JMP Securities
JMP Securities analyst Patrick Walravens reiterated his Outperform rating and $48 price target on Cornerstone OnDemand (CSOD) after CNBC said last week that Amazon's (AMZN) Amazon Web Services is "considering a service for companies to show training content to their employees," and further suggested that Amazon had "explored the learning-management field and concluded that none of the available tools were just right for its own workers," that the company would "build its own system," and that the "idea was to build something 'commercializable.'" Walravens views any weakness in the stock from this news as a buying opportunity, as his due diligence with industry sources int he Cornerstone ecosystem "suggest that these concerns may be overblown."
05/15/18
NEED
05/15/18
NO CHANGE
Target $60
NEED
Strong Buy
Cornerstone OnDemand price target raised to $60 from $55 at Needham
Needham analyst Scott Berg raised his price target on Cornerstone OnDemand to $60 following his meetings with the company CFO Brian Swartz, saying he came away "more positive" on its ability to achieve its $150M free cash flow target by 2020. Berg also believes the company's new strategic initiatives can produce "consistent subscription revenue growth over the near-term", adding that the stock is undervalued given that its growth vectors in Recruiting and in Content are "ripe markets for well positioned product". The analyst further notes that the involvement by Silver Lake in refocusing the sales force has been positive for Cornerstone OnDemand.
CVON ConvergeOne
$9.15

0.24 (2.69%)

04/24/18
04/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. First Data (FDC) initiated with a Buy at Mizuho. 2. Allergan (AGN) resumed with a Buy at Citi. 3. Alder Biopharmaceuticals (ALDR) initiated with a Neutral at Goldman Sachs. 4. ConvergeOne (CVON) initiated with an Outperform at Cowen. 5. Aeglea BioTherapeutics (AGLE) initiated with an Outperform at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/04/18
JPMS
05/04/18
INITIATION
Target $11
JPMS
Overweight
ConvergeOne initiated with an Overweight at JPMorgan
JPMorgan analyst Tien-tsin Huang started ConvergeOne with an Overweight rating and $11 price target. The analyst likes the company as a "niche solutions provider to the complex collaboration market."
05/04/18
05/04/18
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pieris Pharmaceuticals (PIRS) initiated with an Outperform at Cowen. 2. Extraction Oil & Gas (XOG) and ConvergeOne (CVON) were initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/24/18
COWN
04/24/18
INITIATION
Target $12
COWN
Outperform
ConvergeOne initiated with an Outperform at Cowen
Cowen initiated ConvergeOne with an Outperform and $12 price target.
UPLD Upland Software
$31.20

-0.24 (-0.76%)

03/09/18
RHCO
03/09/18
NO CHANGE
Target $32
RHCO
Buy
Upland Software price target raised to $32 from $28 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Upland Software to $32 and kept his Buy rating after the company's Q4 earnings beat. Tillman notes that Upland Software is making progress toward its 40% EBITDA margin target, adding that he also remains confident in the company's acquisition-driven growth strategy amid its robust pipeline and ready access to capital.
03/09/18
NEED
03/09/18
NO CHANGE
Target $32
NEED
Buy
Upland Software price target raised to $32 at Needham after 'very good Q4'
Needham analyst Scott Berg raised his price target on Upland Software to $32 from $29 and kept his Buy rating following a Q4 earnings beat and a "very good" revenue number. Berg says he was particularly impressed with the company's total new logos growing to 151 from 106 and major accounts rising to 19 from 7 relative to last year's Q4. The analyst sees this success as indicative of Upland Software's organic growth rate accelerating to mid-single-digits from historical low-single-digit levels.
03/23/18
CHLM
03/23/18
NO CHANGE
Target $36
CHLM
Buy
Upland Software price target raised to $36 from $32 at Craig-Hallum
Craig-Hallum analyst Jeff Van Rhee raised his price target for Upland Software to $36 from $32 after the company announced the acquisition of InterFax Communications. The analyst reiterates a Buy rating on the shares.
03/23/18
RHCO
03/23/18
NO CHANGE
Target $36
RHCO
Buy
Upland Software price target raised to $36 from $32 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Upland Software to $36 following its purchase of Europe's InterFAX as announced yesterday after market close. The analyst notes that the acquisition will expand Upland's Workflow Automation product family offerings. Tillman adds that the valuation on the stock at 5.1-times enterprise value to 2019 expected sales is attractive, keeping the Buy rating on Upland Software.
SFLY Shutterfly
$92.41

0.08 (0.09%)

05/02/18
05/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Juniper was (JNPR) upgraded to Buy from Neutral at BofA/Merrill and to Hold from Sell at Deutsche Bank. 2. Aetna (AET) upgraded to Overweight from Neutral at Cantor Fitzgerald with analyst Steven Halper saying he views the risk/reward on shares as "more compelling" following the company's first quarter results. 3. Freeport McMoRan (FCX) upgraded to Outperform from Neutral at CIBC with analyst Oscar Cabrera saying shares have dropped over 20% following the Q1 report, reflecting a worst-case scenario for the Indonesia scenario. 4. Shutterfly (SFLY) upgraded to Neutral from Sell at Goldman Sachs with analyst Christopher Merwin citing the better than expected Q1 report. 5. CommScope (COMM) upgraded to Outperform from Market Perform at Northland with analyst Tim Savageaux saying he believes the company's unique mix of exposure to Tier 1 carrier investment in both fiber optic and 4G/5G wireless infrastructure offers compelling value following the sharp pullback in shares after only a "fairly modest" cut to its EPS expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/06/18
BARD
04/06/18
NO CHANGE
Target $85
BARD
Neutral
Shutterfly price target raised to $85 from $68 at Baird
Baird analyst Colin Sebastian raised his estimates on Shutterfly and increased his price target to $85 to reflect the acquisition of Lifetouch. He believes there is likely upside to estimates one-year out as synergies kick in and said his estimates could prove to be conservative. He cited the increasing scale/margins and moderating technology spending. Sebastian maintained his Neutral rating on Shutterfly shares.
05/02/18
GSCO
05/02/18
UPGRADE
Target $87
GSCO
Neutral
Shutterfly upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Christopher Merwin upgraded Shutterfly to Neutral and raised its price target to $87 from $50 following the better than expected Q1 report. Merwin believes the Lifetouch acquisition has "re-rated the earnings power," creating an opportunity for increased cost and revenue synergies, and has smoothed out seasonality.
05/02/18
RHCO
05/02/18
NO CHANGE
Target $100
RHCO
Buy
Shutterfly price target raised to $100 from $70 at SunTrust
SunTrust analyst Youssef Squali raised his price target on Shutterfly to $100 after the company's Q1 earnings beat and raised FY18 forecasts, citing its "improving core Consumer segment" and the benefits of Lifetouch acquisition. The analyst says Shutterfly is also seeing positive momentum from the launch of new products, while its newly restructured platform marks the end of the first stage of its turnaround. Squali keeps his Buy rating on Shutterfly given its "promising outlook and compelling valuation".
EFII Electronics for Imaging
$33.25

0.1 (0.30%)

01/10/18
LEHM
01/10/18
DOWNGRADE
Target $31
LEHM
Underweight
Electronics for Imaging downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Joseph Wolf downgraded Electronics for Imaging to Underweight and cut his price target for the shares to $31 from $33. The analyst believes the company needs "close to flawless" execution as a minimum requirement for the shares to perform. He sees relatively high risk in the stock.
01/10/18
LEHM
01/10/18
UPGRADE
Target $67
LEHM
Overweight
Lumentum upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Joseph Wolf upgraded Lumentum (LITE) to Overweight and raised his price target for the shares to $67 from $65. The analyst coupled the upgrade with a downgrade this morning of Electronics for Imaging (EFII) to Underweight from Equal Weight. Lumentum remains the market share leader at Apple (AAPL) and seems well positioned to take advantage of other opportunities, Wolf tells investors in a research note. He thinks investors should take advantage of the current stock price to add to positions in anticipation of strong results for the next 12-18 months.
11/14/17
WELS
11/14/17
INITIATION
WELS
Market Perform
Electronics for Imaging initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Aaron Rakers initiated coverage of Electronics for Imaging with a Market Perform rating and $32 price target.
12/27/17
NEED
12/27/17
NO CHANGE
NEED
Electronics for Imaging, Kornit among Needham's top Advanced Industrial ideas
Needham analyst James Ricchiuti noted that stocks the firm covers in the Advanced Industrial Technologies space saw "a remarkable performance" in 2017. The economic backdrop seems "brighter than at any time since before the Great Recession" and he believes many of the same underlying growth drivers will remain in place in 2018. The top ideas for 2018 he highlighted include Electronics for Imaging (EFII), Kornit Digital (KRNT), II-VI (IIVI), Zebra Technologies (ZBRA) and Impinj (PI).
ENVA Enova International
$34.05

1.525 (4.69%)

07/12/17
MAXM
07/12/17
INITIATION
Target $18
MAXM
Buy
Enova International initiated with a Buy at Maxim
Maxim analyst Michael Diana started Enova International with a Buy rating and $18 price target, citing its ability to grow share in the very large market for nonprime "personal" loans.
CMPR Cimpress
$138.22

0.05 (0.04%)

11/14/17
BRRR
11/14/17
NO CHANGE
Target $125
BRRR
Outperform
Cimpress price target raised to $125 from $110 at Barrington
Barrington analyst Kevin Steinke raised his price target for Cimpress to $125 from $110 after its Q1 2018 results showed "solid top-line momentum," and based on a strengthening revenue outlook and the company's significant scale and competitive advantages. The analyst reiterates an Outperform rating on the shares.
01/26/18
AGIS
01/26/18
DOWNGRADE
AGIS
Sell
Cimpress downgraded to Sell from Hold at Aegis
09/18/17
BRRR
09/18/17
UPGRADE
Target $110
BRRR
Outperform
Cimpress upgraded to Outperform from Market Perform at Barrington
Barrington analyst Kevin Steinke upgraded Cimpress to Outperform saying the company's investments in 2017 should drive "substantially higher" profits in fiscal year 2018. Management believes the Vistaprint business unit has begun a multi-year return to stronger growth, Steinke tells investors in a research note. He has a $110 price target for the shares.
08/15/17
RHCO
08/15/17
INITIATION
RHCO
Hold
Cimpress assumed with a Hold at SunTrust
SunTrust analyst Youssef Squali assumed coverage of Cimpress with a Hold rating and $85 price target.
AMBR Amber Road
$9.35

-0.06 (-0.64%)

02/13/18
STFL
02/13/18
NO CHANGE
Target $12
STFL
Buy
Amber Road rejection of bid likely start, not end, of process, says Stifel
Stifel analyst Tom Roderick noted the speed with which Amber Road rejected the unsolicited $10.50/share takeover offer made public by E2Open, which he reads as an indication that the bid had "already been rejected behind closed doors, or at the very least, was under slow consideration." He thinks this is likely to be the beginning, rather than the end, of a process and believes a competitive process could potentially yield a modestly higher offer. Roderick keeps his Buy rating and $12 price target on Amber Road shares.
02/16/18
ADAM
02/16/18
DOWNGRADE
ADAM
Hold
Amber Road downgraded to Hold from Buy at Canaccord
02/16/18
ADAM
02/16/18
DOWNGRADE
ADAM
Hold
Amber Road downgraded to Hold after 40% rally at Canaccord
Canaccord Genuity analyst David Hynes downgraded Amber Road to Hold from Buy citing valuation with the shares up 40% this week. The analyst expects the company's growth in 2018 will be a "bit better" than 2017, but not by much. He believes the next leg higher in the shares will take time.
RUBI Rubicon Project
$2.15

0.03 (1.42%)

01/22/18
CHLM
01/22/18
UPGRADE
CHLM
Buy
Rubicon Project upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst Jason Kreyer upgraded Rubicon Project to Buy from Hold as he believes it is positioned to benefit from changing trends across the ad tech industry. Moves to adopt first-price auctions, eliminate buyer fees, and invest in server-side technology have already begun to drive improvements in ad requests and a lift in win-rates, positioning Rubicon to perform well in 2018, he contends. The analyst also argues that these industry tailwinds combined with modest cost reductions to be deployed later should drive continued improvements in adjusted EBITDA, likely lifting shares higher.
03/15/18
RHCO
03/15/18
UPGRADE
RHCO
Buy
Rubicon Project upgraded to Buy from Hold at SunTrust
03/15/18
RHCO
03/15/18
UPGRADE
Target $3
RHCO
Buy
Rubicon Project upgraded to Buy at SunTrust amid 'stabilizing fundamentals'
As reported earlier, SunTrust analyst Matthew Thornton upgraded Rubicon Project to Buy from Hold while keeping the $3 price target. The analyst points to the company's stabilizing fundamentals such as improving advertising spending and take rate as well as new cost actions that should lead to higher profitability. Thornton anticipates the company to remain supported in the growing market given Rubicon's "improved header bidding and auctioning tools".
VDSI Ticker changed to OSPN
$20.80

0.45 (2.21%)

06/26/17
IMPC
06/26/17
INITIATION
Target $16
IMPC
Outperform
Vasco Data Security initiated with an Outperform at Imperial Capital
Imperial Capital analyst Saliq Khan started Vasco Data Security with an Outperform rating and $16 price target. Identity verification "has become ever more important in today's digital and tech-enabled world," the analyst contends.
05/10/18
IMPC
05/10/18
DOWNGRADE
Target $19
IMPC
In-Line
Vasco Data Security downgraded to In-Line from Outperform at Imperial Capital
Imperial Capital analyst Saliq Khan downgraded Vasco Data Security to In-Line from Outperform, citing valuation. The company's strong first quarter was a result of doubling of the mobile security software and further growth of its eSignLive e-signature solution, said Khan, who thinks the mix of hardware and non-hardware could return Vasco's gross margins to around 70%-71% for FY18. Khan raised his price target on Vasco shares to $19 from $16.
05/09/18
DOTC
05/09/18
UPGRADE
Target $21
DOTC
Buy
Vasco Data Security upgraded to Buy at Dougherty
As previously reported, Dougherty upgraded Vasco Data Security to Buy from Neutral with a $21 price target. Analyst Catherine Trebnick said Vasco reported solid Q1 results on a top line beat and very strong margins. Trebnick said Vasco is reporting more consistent performance in the non-hardware segment, with growth potential for eSignLive and expects the upcoming extension of the Trusted Identity Platform will drive significant non-hardware contribution with potential for margin and earnings expansion.
05/09/18
DOTC
05/09/18
UPGRADE
DOTC
Buy
Vasco Data Security upgraded to Buy from Neutral at Dougherty
JCOM j2 Global
$85.59

0.23 (0.27%)

02/02/18
DADA
02/02/18
INITIATION
Target $95
DADA
Buy
j2 Global initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated j2 Global with a Buy rating and a price target of $95, saying the company acquisition strategy is akin to private equity in "buying underperforming assets in cloud services and digital media and achieving scale through a roll-up strategy". The analyst is also positive on j2 Global's operating margin expansion and potential for further gains along with its attractive valuation relative to the peer group.
05/09/18
DADA
05/09/18
NO CHANGE
Target $100
DADA
Buy
j2 Global price target raised to $100 from $95 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on J2 Global to $100 after its Q1 earnings, saying the results were driven by a 16% revenue increase in digital media. The analyst notes that the segment is increasingly more focused on subscription revenue, which has grown to 22% of digital media's total sales from 12% last quarter, adding that EBITDA margins are also expected to improve after some compression in Q1. Jaluria keeps his Buy rating on J2 Global.

TODAY'S FREE FLY STORIES

CBRL

Cracker Barrel

$143.77

-6.93 (-4.60%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel needs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BABA

Alibaba

$156.64

-2.12 (-1.34%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Periodicals
China's Alibaba to set up dedicated chip subsidiary, Reuters reports »

Alibaba is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ABUS

Arbutus Biopharma

$9.55

0.25 (2.69%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Conference/Events
Arbutus Biopharma management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BABA

Alibaba

$156.64

-2.12 (-1.34%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Recommendations
Alibaba analyst commentary  »

Alibaba Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ARPO

Aerpio Pharmaceuticals

$3.77

0.155 (4.29%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Initiation
Aerpio Pharmaceuticals initiated  »

Aerpio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

BK

BNY Mellon

$51.45

0.23 (0.45%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Hot Stocks
KPMG admits misconduct on BNY Mellon reports, says watchdog »

The Financial Reporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 18

    Oct

RNSDF

Renault

$0.00

(0.00%)

, VLKAY

Volkswagen

$0.00

(0.00%)

06:25
09/19/18
09/19
06:25
09/19/18
06:25
Periodicals
Renault, VW, Fiat Chrysler sales surged before new emissions test, Reuters says »

Renault (RNSDF),…

RNSDF

Renault

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

FCAU

Fiat Chrysler

$17.62

0.17 (0.97%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$87.33

-6.44 (-6.87%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Syndicate
Argenx 3.48M share Secondary priced at $86.50 »

Morgan Stanley, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Sep

NFLX

Netflix

$367.85

17.61 (5.03%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Hot Stocks
NY Attorney General: Cryptocurrency exchanges lack integrity, security, fairness »

New York Attorney General…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REVB

Revere Bank

$0.00

(0.00%)

06:20
09/19/18
09/19
06:20
09/19/18
06:20
Syndicate
Revere Bank 1.4M share Secondary priced at $29.25 »

Sandler ONeill acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GTHX

G1 Therapeutics

$62.94

-3.41 (-5.14%)

06:20
09/19/18
09/19
06:20
09/19/18
06:20
Syndicate
G1 Therapeutics 3M share Secondary priced at $60.00 »

JPMorgan and Cowen acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Sep

NVS

Novartis

$85.03

-0.1 (-0.12%)

06:18
09/19/18
09/19
06:18
09/19/18
06:18
Hot Stocks
Novartis' Kymriah for adult lymphoma 'to expensive to recommend,' says NICE »

The U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CNC

Centene

$142.82

1.055 (0.74%)

06:17
09/19/18
09/19
06:17
09/19/18
06:17
Initiation
Centene initiated  »

Centene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 23

    Oct

  • 14

    Dec

GM

General Motors

$35.11

0.09 (0.26%)

, TSLA

Tesla

$284.88

-9.9 (-3.36%)

06:17
09/19/18
09/19
06:17
09/19/18
06:17
Periodicals
Former GM exec Lutz says Tesla is 'headed for the graveyard', CNBC reports »

Bob Lutz, former vice…

GM

General Motors

$35.11

0.09 (0.26%)

TSLA

Tesla

$284.88

-9.9 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

AAPL

Apple

06:14
09/19/18
09/19
06:14
09/19/18
06:14
Recommendations
Apple analyst commentary  »

Apple offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, IQ

iQIYI

$26.29

-0.54 (-2.01%)

06:14
09/19/18
09/19
06:14
09/19/18
06:14
Periodicals
Tencent Music cuts size of U.S. IPO to $2B, Reuters reports »

Chinese music-streaming…

TCEHY

Tencent

$0.00

(0.00%)

IQ

iQIYI

$26.29

-0.54 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$11.93

0.335 (2.89%)

, RDC

Rowan Companies

$16.25

0.56 (3.57%)

06:13
09/19/18
09/19
06:13
09/19/18
06:13
Upgrade
Transocean, Rowan Companies, Ensco, Noble Corp. rating change  »

Transocean upgraded to…

RIG

Transocean

$11.93

0.335 (2.89%)

RDC

Rowan Companies

$16.25

0.56 (3.57%)

ESV

Ensco

$7.40

0.28 (3.93%)

NE

Noble Corp.

$6.15

0.19 (3.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SIR

Select Income REIT

$20.53

-1.18 (-5.44%)

06:13
09/19/18
09/19
06:13
09/19/18
06:13
Upgrade
Select Income REIT rating change  »

Select Income REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RFP

Resolute Forest

$14.65

0.125 (0.86%)

06:12
09/19/18
09/19
06:12
09/19/18
06:12
Downgrade
Resolute Forest rating change  »

Resolute Forest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$109.55

0.18 (0.16%)

06:11
09/19/18
09/19
06:11
09/19/18
06:11
Periodicals
Marvel heroes to get own TV series on Disney streaming service, Variety reports »

Disney is in early…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MCD

McDonald's

$157.77

-0.38 (-0.24%)

06:10
09/19/18
09/19
06:10
09/19/18
06:10
Hot Stocks
EU says McDonald's, Luxembourg tax deal not illegal »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ETFC

E-Trade

$53.77

0.46 (0.86%)

06:08
09/19/18
09/19
06:08
09/19/18
06:08
Upgrade
E-Trade rating change  »

E-Trade upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$114.86

-0.6 (-0.52%)

06:07
09/19/18
09/19
06:07
09/19/18
06:07
Recommendations
Wabco analyst commentary  »

Wabco target lowered to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 06

    Nov

FB

Facebook

$160.31

-0.29 (-0.18%)

06:05
09/19/18
09/19
06:05
09/19/18
06:05
Periodicals
Facebook pressed banks for ability to use financial data for ads, WSJ reports »

As recently as last year,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.